Identifying and treating resistant hypertension in PRECISION: A randomized long‐term clinical trial with aprocitentan

Abstract The design and baseline data of the PRECISION study, which evaluates the effect of the dual endothelin receptor antagonist aprocitentan on blood pressure (BP) in patients with resistant hypertension (RHT) are presented. The study is a blinded, randomized, parallel‐group Phase 3 study and it...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Parisa Danaietash, Pierre Verweij, Ji‐Guang Wang, George Dresser, Ilkka Kantola, Mary Katherine Lawrence, Krzysztof Narkiewicz, Markus Schlaich, Marc Bellet, the PRECISION investigators
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	Wiley 2022-07-01
श्रृंखला:	The Journal of Clinical Hypertension
विषय:	aprocitentan blood pressure endothelin receptor antagonist pseudoresistant hypertension
ऑनलाइन पहुंच:	https://doi.org/10.1111/jch.14517
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!